These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 26589198)

  • 1. Erase and Rewind: Epigenetic Conversion of Cell Fate.
    Pennarossa G; Zenobi A; Gandolfi CE; Manzoni EF; Gandolfi F; Brevini TA
    Stem Cell Rev Rep; 2016 Apr; 12(2):163-70. PubMed ID: 26589198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear reprogramming strategy modulates differentiation potential of induced pluripotent stem cells.
    Martinez-Fernandez A; Nelson TJ; Terzic A
    J Cardiovasc Transl Res; 2011 Apr; 4(2):131-7. PubMed ID: 21207217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotype switching through epigenetic conversion.
    Brevini TA; Pennarossa G; Maffei S; Gandolfi F
    Reprod Fertil Dev; 2015 Jun; 27(5):776-83. PubMed ID: 25739562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstacles in Renal Regenerative Medicine: Metabolic and Epigenetic Parallels Between Cellular Reprogramming and Kidney Cancer Oncogenesis.
    Lichner Z; Mac-Way F; Yousef GM
    Eur Urol Focus; 2019 Mar; 5(2):250-261. PubMed ID: 28847686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unveiling epigenetic regulation in cancer, aging, and rejuvenation with in vivo reprogramming technology.
    Sogabe Y; Seno H; Yamamoto T; Yamada Y
    Cancer Sci; 2018 Sep; 109(9):2641-2650. PubMed ID: 29989289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a High-Efficacy Reprogramming Method for Generating Human Induced Pluripotent Stem (iPS) Cells from Pathologic and Senescent Somatic Cells.
    Tanaka N; Kato H; Tsuda H; Sato Y; Muramatsu T; Iguchi A; Nakajima H; Yoshitake A; Senbonmatsu T
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular reprogramming to reset epigenetic signatures.
    Hewitt KJ; Garlick JA
    Mol Aspects Med; 2013; 34(4):841-8. PubMed ID: 22982217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age reprogramming and epigenetic rejuvenation.
    Singh PB; Newman AG
    Epigenetics Chromatin; 2018 Dec; 11(1):73. PubMed ID: 30572909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pluripotency, Differentiation, and Reprogramming: A Gene Expression Dynamics Model with Epigenetic Feedback Regulation.
    Miyamoto T; Furusawa C; Kaneko K
    PLoS Comput Biol; 2015 Aug; 11(8):e1004476. PubMed ID: 26308610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
    de Lázaro I; Yilmazer A; Kostarelos K
    J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic reprogramming of cell identity: lessons from development for regenerative medicine.
    Basu A; Tiwari VK
    Clin Epigenetics; 2021 Jul; 13(1):144. PubMed ID: 34301318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular reprogramming.
    Takahashi K
    Cold Spring Harb Perspect Biol; 2014 Feb; 6(2):. PubMed ID: 24492711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Regulation of Cardiomyocyte Differentiation from Embryonic and Induced Pluripotent Stem Cells.
    Kim YJ; Tamadon A; Kim YY; Kang BC; Ku SY
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum starvation-induced cell cycle synchronization stimulated mouse rDNA transcription reactivation during somatic cell reprogramming into iPSCs.
    Zhao Q; Wu Y; Shan Z; Bai G; Wang Z; Hu J; Liu L; Li T; Shen J; Lei L
    Stem Cell Res Ther; 2016 Aug; 7(1):112. PubMed ID: 27515169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of somatic cell reprogramming.
    Wang Y; Bi Y; Gao S
    Curr Opin Genet Dev; 2017 Oct; 46():156-163. PubMed ID: 28823984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selected small molecules as inducers of pluripotency.
    Baranek M; Markiewicz WT; Barciszewski J
    Acta Biochim Pol; 2016; 63(4):709-716. PubMed ID: 27785481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xenopatients 2.0: reprogramming the epigenetic landscapes of patient-derived cancer genomes.
    Menendez JA; Alarcón T; Corominas-Faja B; Cuyàs E; López-Bonet E; Martin AG; Vellon L
    Cell Cycle; 2014; 13(3):358-70. PubMed ID: 24406535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.
    Rony IK; Baten A; Bloomfield JA; Islam ME; Billah MM; Islam KD
    Cell Prolif; 2015 Apr; 48(2):140-56. PubMed ID: 25643745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.